Peter J. Henry
Department of Pharmacology
University of Western Australia
Nedlands
Australia
Name/email consistency: high
- The protease-activated receptor2 (PAR2)-prostaglandin E2-prostanoid EP receptor axis: a potential bronchoprotective unit in the respiratory tract?. Henry, P.J. Eur. J. Pharmacol. (2006)
- A rho kinase inhibitor, Y-27632 inhibits pulmonary eosinophilia, bronchoconstriction and airways hyperresponsiveness in allergic mice. Henry, P.J., Mann, T.S., Goldie, R.G. Pulm. Pharmacol. Ther (2005)
- Inhibitors of prostaglandin transport and metabolism augment protease-activated receptor-2-mediated increases in prostaglandin E2 levels and smooth muscle relaxation in mouse isolated trachea. Henry, P.J., D'Aprile, A., Self, G., Hong, T., Mann, T.S. J. Pharmacol. Exp. Ther. (2005)
- An endothelin receptor antagonist, SB-217242, inhibits airway hyperresponsiveness in allergic mice. Henry, P.J., Mann, T.S., D'Aprile, A.C., Self, G.J., Goldie, R.G. Am. J. Physiol. Lung Cell Mol. Physiol. (2002)
- Endothelin receptor distribution and function in the airways. Henry, P.J. Clin. Exp. Pharmacol. Physiol. (1999)
- Typical endothelin ETA receptors mediate atypical endothelin-1-induced contractions in sheep isolated tracheal smooth muscle. Henry, P.J., King, S.H. J. Pharmacol. Exp. Ther. (1999)









